Expansion of Interleukin‐22‐Producing Type 3 Innate Lymphoid Cells in the Gut of Tristetraprolin‐Deficient Mice
Tristetraprolin (TTP, encoded by Zfp36) is an RNA-binding protein that plays a major role in the control of inflammation. Zfp36<sup>-/-</sup> mice spontaneously develop a complex multiorgan inflammatory syndrome but no overt intestinal inflammation, suggesting the involvement of local regulatory mechanisms. In this study, we observed local expansion of IL-22-producing type 3 innate lymphoid cells (ILC3s) in the lamina propria of Zfp36<sup>-/-</sup> mice. Our findings demonstrate that this expansion was primarily influenced by cell-extrinsic cues. In the absence of IL-22, we observed delayed onset of arthritis in Zfp36<sup>-/-</sup> mice but no clear evidence of exacerbated intestinal inflammation under steady-state conditions. However, we show that Zfp36<sup>-/-</sup> mice were paradoxically protected from dextran sulfate sodium (DSS)-induced colitis and suggest that increased IL-22 production by ILC3 might contribute to this observation. Taken together, these data highlight the complex interplay between systemic inflammation and gut mucosal immune homeostasis.
Authors
- Ingrid Dubois
- Lara Meyer
- Muriel Nguyen
- Caroline La
- Sylvie Vande Velde (ORCID: https://orcid.org/0009-0004-0951-2456)
- Laure Dumoutier (ORCID: https://orcid.org/0000-0002-6645-684X)
- Perry J. Blackshear (ORCID: https://orcid.org/0000-0002-9561-8529)
- Maxime Melchior
- Stanislas Goriely (ORCID: https://orcid.org/0000-0002-7005-6195)
- Céline La (ORCID: https://orcid.org/0000-0002-6065-2970)
- Abdulkader Azouz (ORCID: https://orcid.org/0000-0001-8626-4370)
- Bérengère de de Toeuf (ORCID: https://orcid.org/0000-0002-3276-7594)
- Séverine Thomas (ORCID: https://orcid.org/0000-0002-3063-2821)
- Aresio Villanueva Alcantara
- Frédérick Libert
- Vincent Martens
Institutions
- Université Libre de Bruxelles (BE)
- National Institute of Environmental Health Sciences (US)
- de Duve Institute (BE)
Publication Details
- Journal
- European Journal of Immunology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/eji.202350892
- Citations
- 1
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Fonds Erasme
- European Regional Development Fund